Thomas A. McCourt, Chief Executive Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 53,264 shares at $10.70 ($570K) on 2023-05-30, disclosed to the SEC on 2023-06-01.
Scheduled sale ($570k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.70 | 26,632 | $285K | 50.0% |
| 2 | $10.70 | 26,632 | $285K | 50.0% |
| Total | $10.70 avg | 53,264 | $570K | 100% |
| Filing → |
| IRWD | SELL | 2025-02-12 | $490K | — | Filing → |
| IRWD | SELL | 2024-05-22 | $872K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $5.4M | — | Filing → |